The soaring demand for antidiabetic and weight-loss drugs has lured in many biotech and big Pharma companies. Onto this ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...

THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART ...

Semaglutide mimics the action of the natural protein glucagon-like peptide 1(GLP-1), a hormone from a family of chemical messengers called the incretins, which Belgian physiologist Jean LaBarre ...

via REUTERS Semaglutide — the active ingredient in Ozempic and Wegovy — is part of a class of drugs that mimic the body’s natural GLP-1 hormone, making users feel fuller for longer.

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different ...

GLP-1 (Glucagon-Like Peptide-1) analogues are synthetic drugs designed to mimic the action of the naturally occurring GLP-1 hormone, which plays a critical role in glucose metabolism. These analogues ...